NCT00370331 - RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag | Biotech Hunter

Enrollment

197

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Purpura, Thrombocytopaenic, Idiopathic

Interventions

DRUG

eltrombopag

Subjects will initiate treatment with either 50 mg eltrombopag or matching placebo once daily. Based upon the subjects platelet count at each visit, the dose of eltrombopag may be adjusted either up or down.

DRUG

Placebo

Trial Locations (115)

100

GSK Investigational Site, Taipei

110

GSK Investigational Site, Taipei

114

GSK Investigational Site, Taipei

1003

GSK Investigational Site, Grafton

1008

GSK Investigational Site, Tunis

1309

GSK Investigational Site, Auckland

1701

GSK Investigational Site, Auckland

3029

GSK Investigational Site, Sfax

4000

GSK Investigational Site, Sousse

5000

GSK Investigational Site, Odense

8011

GSK Investigational Site, Christchurch

10029

GSK Investigational Site, New York

10065

GSK Investigational Site, New York

10676

GSK Investigational Site, Athens

11527

GSK Investigational Site, Athens

13353

GSK Investigational Site, Berlin

14033

GSK Investigational Site, Caen

14215

GSK Investigational Site, Buffalo

15123

GSK Investigational Site, Athens

19090

GSK Investigational Site, Willow Grove

20007

GSK Investigational Site, Washington D.C.

20132

GSK Investigational Site, Milan

22205

GSK Investigational Site, Arlington

28006

GSK Investigational Site, Madrid

28040

GSK Investigational Site, Madrid

30341

GSK Investigational Site, Atlanta

30625

GSK Investigational Site, Hanover

31405

GSK Investigational Site, Savannah

33021

GSK Investigational Site, Hollywood

33604

GSK Investigational Site, Pessac

35128

GSK Investigational Site, Padua

35392

GSK Investigational Site, Giessen

36100

GSK Investigational Site, Vicenza

40138

GSK Investigational Site, Bologna

44106

GSK Investigational Site, Cleveland

49102

GSK Investigational Site, Dnipropetrovsk

57010

GSK Investigational Site, Thessaloniki

63110

GSK Investigational Site, St Louis

65025

GSK Investigational Site, Odesa

66113

GSK Investigational Site, Saarbrücken

70210

GSK Investigational Site, Kuopio

71201

GSK Investigational Site, Heraklion, Crete

73505

GSK Investigational Site, Lawton

75137

GSK Investigational Site, Dallas

77030

GSK Investigational Site, Houston

79044

GSK Investigational Site, Lviv

79410

GSK Investigational Site, Lubbock

79415

GSK Investigational Site, Lubbock

80131

GSK Investigational Site, Napoli

80639

GSK Investigational Site, Munich

90033

GSK Investigational Site, Los Angeles

91010

GSK Investigational Site, Duarte

93003

GSK Investigational Site, Bobigny

94010

GSK Investigational Site, Créteil

94143

GSK Investigational Site, San Francisco

96813

GSK Investigational Site, Honolulu

97227

GSK Investigational Site, Portland

98109

GSK Investigational Site, Seattle

98405

GSK Investigational Site, Tacoma

125167

GSK Investigational Site, Moscow

193024

GSK Investigational Site, Saint Petersburg

200025

GSK Investigational Site, Shanghai

215006

GSK Investigational Site, Jiang Su Province

300020

GSK Investigational Site, Tianjin

560002

GSK Investigational Site, Bangalore

630087

GSK Investigational Site, Novosibirsk

20010-2975

GSK Investigational Site, Washington D.C.

02114

GSK Investigational Site, Boston

01655

GSK Investigational Site, Worcester

A-1090

GSK Investigational Site, Vienna

V5H 4K7

GSK Investigational Site, Burnaby

A1B 3V6

GSK Investigational Site, St. John's

L8N 3Z5

GSK Investigational Site, Hamilton

M9N 1N8

GSK Investigational Site, Weston

J4V 2H1

GSK Investigational Site, Greenfield Park

H7M 3L9

GSK Investigational Site, Laval

H2L 4M1

GSK Investigational Site, Montreal

H3T 1E2

GSK Investigational Site, Montreal

625 00

GSK Investigational Site, Brno

500 05

GSK Investigational Site, Hradec Králové

775 20

GSK Investigational Site, Olomouc

128 20

GSK Investigational Site, Prague

Unknown

GSK Investigational Site, Shatin

GSK Investigational Site, Taipei

GSK Investigational Site, Rhyl, Denbighshire

GSK Investigational Site, Ho Chi Minh City

576 104

GSK Investigational Site, Manipal

00041

GSK Investigational Site, Albano Laziale (Roma)

3816 CP

GSK Investigational Site, Amersfoort

6525 GA

GSK Investigational Site, Nijmegen

8025 AB

GSK Investigational Site, Zwolle

Lima 41

GSK Investigational Site, Lima

Lima 27

GSK Investigational Site, Lima

80-952

GSK Investigational Site, Gdansk

31-501

GSK Investigational Site, Krakow

59-200

GSK Investigational Site, Legnica

45-372

GSK Investigational Site, Opole

76-200

GSK Investigational Site, Słupsk

87-100

GSK Investigational Site, Torun

50-367

GSK Investigational Site, Wroclaw

041 90

GSK Investigational Site, Košice

036 59

GSK Investigational Site, Martin

080 01

GSK Investigational Site, Prešov

07014

GSK Investigational Site, Palma de Mallorca

03150

GSK Investigational Site, Kyiv

04112

GSK Investigational Site, Kyiv

PL6 8DH

GSK Investigational Site, Plymouth

TA1 5DA

GSK Investigational Site, Taunton

LS1 3EX

GSK Investigational Site, Leed

E1 1BB

GSK Investigational Site, London

NW1 2BU

GSK Investigational Site, London

SE5 9RS

GSK Investigational Site, London

M13 9WL

GSK Investigational Site, Manchester

SA6 6NL

GSK Investigational Site, Morriston

RG1 5AN

GSK Investigational Site, Reading